Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2010

Candidate genes for alcohol preference identified by expression
profiling in alcohol-preferring and -nonpreferring reciprocal
congenic rats
Tiebing Liang
Indiana University - Purdue University Indianapolis

Mark W. Kimpel
Indiana University - Purdue University Indianapolis

Jeanette N. McClintick
Indiana University - Purdue University Indianapolis

Ashley R. Skillman
Indiana University - Purdue University Indianapolis

Kevin McCall
Washington University School of Medicine in St. Louis

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Liang, Tiebing; Kimpel, Mark W.; McClintick, Jeanette N.; Skillman, Ashley R.; McCall, Kevin; Edenberg,
Howard J.; and Carr, Lucinda G., ,"Candidate genes for alcohol preference identified by expression profiling
in alcohol-preferring and -nonpreferring reciprocal congenic rats." Genome Biology. 11,. R11. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/92

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Authors
Tiebing Liang, Mark W. Kimpel, Jeanette N. McClintick, Ashley R. Skillman, Kevin McCall, Howard J.
Edenberg, and Lucinda G. Carr

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/
open_access_pubs/92

Liang et al. Genome Biology 2010, 11:R11
http://genomebiology.com/2010/11/2/R11

RESEARCH

Open Access

Candidate genes for alcohol preference identified
by expression profiling in alcohol-preferring and
-nonpreferring reciprocal congenic rats
Tiebing Liang1*, Mark W Kimpel2, Jeanette N McClintick3, Ashley R Skillman1, Kevin McCall4, Howard J Edenberg3,
Lucinda G Carr1

Abstract
Background: Selectively bred alcohol-preferring (P) and alcohol-nonpreferring (NP) rats differ greatly in alcohol
preference, in part due to a highly significant quantitative trait locus (QTL) on chromosome 4. Alcohol
consumption scores of reciprocal chromosome 4 congenic strains NP.P and P.NP correlated with the introgressed
interval. The goal of this study was to identify candidate genes that may influence alcohol consumption by
comparing gene expression in five brain regions of alcohol-naïve inbred alcohol-preferring and P.NP congenic rats:
amygdala, nucleus accumbens, hippocampus, caudate putamen, and frontal cortex.
Results: Within the QTL region, 104 cis-regulated probe sets were differentially expressed in more than one region,
and an additional 53 were differentially expressed in a single region. Fewer trans-regulated probe sets were
detected, and most differed in only one region. Analysis of the average expression values across the 5 brain
regions yielded 141 differentially expressed cis-regulated probe sets and 206 trans-regulated probe sets. Comparing
the present results from inbred alcohol-preferring vs. congenic P.NP rats to earlier results from the reciprocal
congenic NP.P vs. inbred alcohol-nonpreferring rats demonstrated that 74 cis-regulated probe sets were
differentially expressed in the same direction and with a consistent magnitude of difference in at least one brain
region.
Conclusions: Cis-regulated candidate genes for alcohol consumption that lie within the chromosome 4 QTL were
identified and confirmed by consistent results in two independent experiments with reciprocal congenic rats.
These genes are strong candidates for affecting alcohol preference in the inbred alcohol-preferring and inbred
alcohol-nonpreferring rats.

Background
Alcoholism has a substantial genetic component, with
estimates of heritability ranging from 50 to 60% for
both men and women [1-3]. The associations of several
genes with risk for alcoholism have been replicated in
human studies: GABRA2 [4-11], ADH4 [12-14], and
CHRM2 [15,16]. Several other genes have been associated with alcoholism or related traits and await replication [17,18], including TAS2R16 [19,20], NTRK2 [21],
GABRG3 [22], GABRA1 [23], OPRK1 and PDYN
[24,25], NFKB1 [26], ANKK1 [27], ACN9 [28], TACR3
* Correspondence: tliang@iupui.edu
1
Indiana University School of Medicine, Department of Medicine, IB424G, 975
West Walnut Street, Indianapolis, IN 46202, USA

[29], CHRNA5 [30], SNCA [31], NPY [32,33], and NPY
receptors [34].
Selected strains of rodents that differ in voluntary
alcohol consumption have been valuable tools to aid in
dissecting the genetic components of alcoholism
[35-38]. The alcohol-preferring (P) and -nonpreferring
(NP) rat lines were developed through bi-directional
selective breeding from a randomly bred, closed colony
of Wistar rats on the basis of alcohol preference in a
two-bottle choice paradigm [36]. P rats display the phenotypic characteristics considered necessary for an animal model of alcoholism [39,40]. Subsequently, inbred
alcohol-preferring (iP) and -nonpreferring (iNP) strains
were established; these inbred strains maintain highly
divergent alcohol consumption scores [41]. Due to the
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physiological and genetic similarity between humans and
rats, iP and iNP rats can be studied to identify important genetic factors that might influence predisposition
to alcoholism in humans.
A highly significant quantitative trait locus (QTL) that
influenced alcohol preference was identified on chromosome 4, with a maximum LOD score of 9.2 in a cross
between iP and iNP rats [41]. The chromosome 4 QTL
acts in an additive fashion and accounts for approximately 11% of the phenotypic variability. This approximately 100 million bases (Mb) QTL region is likely to
harbor genes that directly contribute to alcohol preference. Several candidate genes identified in human studies (SNCA, NPY, CHRM2, TAS2R16, and ACN9) have
homologs located within this rat chromosome 4 QTL.
Snca and Npy have been shown to be differentially
expressed between these two strains [42,43].
Reciprocal congenic strains (Figure 1) in which the iP
chromosome 4 QTL interval was transferred to the iNP
(NP.P-(D4Rat119-D4Rat55) and the iNP chromosome 4
QTL interval was transferred to the iP (P.NP(D4Rat119-D4Rat55) exhibited the expected effect on
alcohol consumption: that is, the consumption correlated with the strain that donated the chromosome 4
QTL interval [44]. (In this paper, the reciprocal congenic strains will be referred to as NP.P and P.NP.)
Thus, the chromosome 4 QTL region is, in part,
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responsible for the disparate alcohol consumption
observed between the iP and iNP rats.
Identifying the genes in the chromosome 4 interval
that underlie the phenotype has been difficult. We
adopted a strategy of using transcriptome analysis to
determine which genes are altered in expression in the
congenic strains; this is a powerful approach toward
gene identification [45-47]. Using this approach reduces
the ‘noise’ from unrelated differences in gene expression,
because the two strains are identical except for the QTL
sequences, and thereby increases the specificity with
which genes contributing to the specific phenotype can
be detected.
Previous transcriptome profiling of the NP.P congenic
strain and the iNP background strain identified 35 candidate genes in the chromosome 4 QTL that were cisregulated in at least one of the five brain regions studied
[47]. Nucleus accumbens, frontal cortex, amygdala, hippocampus, and caudate putamen were examined, based
on their inclusion in the mesolimbic and mesocortical
systems, both of which are important in the initiation
and maintenance of goal-directed and reward-mediated
behaviors [48,49]. In the present paper, we compare the
iP background strain with the reciprocal congenic strain
(P.NP) to identify cis and trans differentially expressed
genes. The strategy of identifying differentially expressed
genes in congenic strains and using comparisons

Figure 1 Development of reciprocal congenic strains. Alcohol-preferring (P) and alcohol-nonpreferring (NP) rats were selectively bred for
high and low alcohol drinking from a closed colony of Wistar rats [36]. Inbreeding was initiated at generation 30 to create the inbred P (iP) and
iNP rats [41]. Chromosome 4 reciprocal congenic rats were developed in which the iP chromosome 4 QTL interval from D4Rat119 to D4Rat55
was transferred to the iNP (NP.P-(D4Rat119-D4Rat55)) and the iNP chromosome 4 QTL interval was transferred to the iP (P.NP-(D4Rat119D4Rat55)) [44]. Genotyping of D4Rat15, D4Rat119, D4Rat55, and D4Rat 192 revealed that the recombination location was between D4Rat15 and
D4Rat119 and between D4Rat55 and D4Rat192 [44].
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between the reciprocal congenic strains to further support the differences allowed us to identify genes that are
strong candidates for affecting alcohol preference.

Results
Cis-regulated genes

Because alcohol preference in the congenic strains correlated with the strain origin of the introgressed region,
our primary hypothesis was that the genes in that region
contributing to the phenotype would differ in expression
as a result of cis-acting elements. Transcriptome analyses were performed to detect differences in gene
expression between iP and congenic P.NP rats in five
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brain regions: nucleus accumbens, frontal cortex, amygdala, hippocampus, and caudate putamen.
Of the probe sets differentially expressed in the introgressed region of chromosome 4, many are located
within the 95% confidence interval of the QTL (54.8 to
105 Mb). (Figure 2) The number of differentially
expressed probe sets (false discovery rate (FDR) ≤ 0.25)
within the QTL was similar in each of the 5 brain
regions, ranging from 72 in the nucleus accumbens to
89 in the hippocampus (Table 1). most probe sets significant in any one brain region were significant in multiple regions; 104 of the 157 cis-regulated probe sets
showed differential expression in more than one brain

Figure 2 Differentially expressed probe sets within the chromosome 4 QTL interval. Top panel: chromosome 4 QTL lod plot, based on
reanalysis of our original data from [101] plus additional genotyping, using the current positions of the markers. The 95% confidence interval for
the QTL is indicated by a horizontal line. The transferred region of the QTL is indicated by vertical lines. Bottom panel: The expression (E) ratios
(EP.NP-EiP)/EiP of the probe sets from approximately 30 Mb to 130 Mb were aligned with the lod plot in the top panel.
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Table 1 Number of differentially expressed probe sets in the iP vs P.NP Comparison
Nucleus
accumbens

Amygdala

Frontal
cortex

Hippocampus

Caudate
putamen

At least one
brain region

Multiple brain
regions

Combined
regions

Total

72

74

78

89

82

157

104

141

Single brain region
only

11

8

7

10

17

Significant cis-regulated
probe sets

Only significant in
combined

19

Significant transregulated probe sets
Total
Single brain region
only
Only significant in
combined

14
9

7
2

16
8

17
10

54
46

85

10

206

143

Cis-regulated probe sets are those located in the chromosome 4 QTL interval; trans-regulated probe sets are located in the remainder of the genome. The first
five columns show the number of cis- and trans-regulated probe sets that differ between iP and P.NP in each individual brain region. ‘At least one brain region’
shows the total number of unique probe sets that differed in one or more regions. ‘Multiple brain regions’ shows the total number of unique probe sets that
differed in at least two of the five brain regions. ‘Average expression’ shows probe sets that differ when the average expression across the five regions in each
animal was analyzed. ‘Single brain region only’ shows the number of unique probe sets significant in only that brain region. ‘In average only’ shows unique
probe sets that were significant only in analysis of the average level of expression across the five regions in each animal.

region. Only 8 to 21% of those detected in any single
region were detected in only that region (Table 1). Analysis of the average level of gene expression across all 5
regions showed 141 probe sets that significantly differed
between the strains; this included 19 probe sets not
detected in any of the individual regions (Table 1; also
see Table S1 in Additional file 1, which includes a list of
significant differentially expressed cis-regulated genes).
Trans-regulated genes

To detect trans-regulated genes (genes identical in the
two strains that are differentially expressed due to variations in a regulatory gene located within the chromosome 4 region), the remainder of the genome
(everything except the chromosome 4 QTL region) was
analyzed. Differentially expressed genes are not concentrated on any chromosome, other than chromosome 4
(Table S2 in Additional file 1). Although the total number of genome probe sets analyzed was much greater
than the QTL probe sets (for example, 23,050 probe
sets were used in the averaged analysis, versus 960 in
the cis-analysis above; see Materials and methods for
details), fewer trans-regulated probe sets were differentially expressed in each region or in multiple regions
(Table 1). Unexpectedly, we found 54 significant probe
sets in the caudate putamen, of which 46 were only significant in that brain region. The analysis of the average
level of gene expression across all 5 regions was more
powerful than the analyses of individual brain regions;
206 trans-regulated probe sets differed, including 143
that did not differ in any individual region (Table 1; also

see Table S2 in Additional file 1, which includes a list of
differentially expressed trans-regulated genes).
Some of the trans-regulated genes were previously
implicated in drug or alcohol addiction, including Pnlip
(pancreatic lipase) [50], Homer1 (homer homolog 1
(Drosophila)) [51], Jun (Jun oncogene), Adhfe1 (alcohol
dehydrogenase, iron containing, 1) [52], Ptprr (protein
tyrosine phosphatase, receptor type, R) [53], Klf15
(Kruppel-like factor 15) [54,55], Nfkb1 (nuclear factor of
kappa light polypeptide gene enhancer in B-cells 1) [26],
Sox18 (SRY-box containing gene 18) [56,57], and Qdpr
(quinoid dihydropteridine reductase) [58,59].
Confirmation by quantitative RT-PCR

To confirm some of the genes that differed in expression between the iP and P.NP, quantitative RT-PCR
(qRT-PCR) was performed using RNA samples of the
brain regions. Ten genes were selected based on literature reports of their possible involvement in pathways
related to alcohol seeking behavior (Table 2). Among
the 44 comparisons with genes that significantly differed
on microarrays, 35 (79%) were differentially expressed in
the same direction when tested by qRT-PCR.
Comparison of reciprocal congenic strains

Previously published data comparing expression in NP.P
versus iNP congenics [47] were compared to the present
data (iP versus P.NP) to identify probe sets that exhibited consistent expression differences between the two
experiments. For both experiments we calculated the
ratio of expression from the animals carrying the iP
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Table 2 Quantitative RT-PCR confirmation
Ratio of expression (iP vs P.NP)a
Nucleus accumbens
Affymetrix
ID

Gene
symbol

Microarray

qRTPCR

Amygdala
Microarray

qRTPCR

Frontal cortex
Microarray

qRTPCR

Hippocampus
Microarray

qRTPCR

Caudate putamen
Microarray

qRTPCR

1368358_a_at Ptprr

2.22

2.28

2.47

2.71

2.17

1.85

2.42

2.77

1.98

2.28

1395714_at

Copg2 IT

-3.97

-2.45

-28.29

-1.73

-31.36

-1.61

-4.57

-2.12

-20.13

-1.23

1394939_at

Ppm1k

-2.05

1.30

-1.74

-1.62

-2.79

-2.54

-1.86

-3.12

-2.39

-2.49

1379275_at

Snx10

1.67

-1.16

2.18

1.68

1.94

1.15

1.69

2.42

2.02

1.64

1.30

1.54

1.22

-1.04

1.21

1.19

1.28

1.58

1.43

1.86

1380094_a_at Zfp212
1367734_at

Akr1b1

1.22

1.13

1.12

1.30

1.27

1.58

1.16

1.06

1.25

1.15

1379480_at
1370007_at

Dgki
Pdia4

1.23
1.24

2.72
1.57

1.13
1.34

-1.26
-1.01

1.17
[1.14]

-2.97
1.05

1.26

1.11

1.25
1.36

-1.71
-1.13

1367977_at

Snca

-1.11

-1.22

[1.07]

1.05

1387154_at

Npy

[-1.11]

1.01

-1.12

-1.09

[-1.08]

-1.20

a
A positive number indicates the ratio of the expression level of iP/P.NP; a negative number indicates the ratio of expression level of P.NP/iP. Bold numbers in
the microarray columns indicate expression is significantly different at FDR <0.05; square brackets indicate FDR between 0.05 and 0.25. qRT-PCR value is an
average of six technical replicates.

QTL region to that from the animals carrying the iNP
QTL region (that is, NP.P/iNP and iP/P.NP). Because
the earlier experiment was less powerful (comparing
only six animals from each strain) and because we could
use the consistency of results from the two experiments
to filter out false positives, we relaxed the level of significance to P ≤ 0.05 for this comparison to reduce false
negatives. Any false positives introduced by this relaxation should not be consistent between the two independent experiments. A total of 74 probesets that were
significant in the two experiments (at P ≤ 0.05) in the
same brain region or in the average of the brain regions
and with consistent direction in both experiments were
identified (Table 3). Additional robust multi-chip average (RMA) data and uncorrected P-value data are
included (Table S3 in Additional file 1). All of the
reproducible probe sets were located within the chromosome 4 QTL interval, and therefore cis-regulated.
The expression differences of these 74 cis-regulated
genes were highly correlated in the two experiments (R2
= 0.88; Figure 3); 71 showed expression differences of
similar amounts in the same direction in both experiments. Thus, these cis-regulated genes are strong candidates for affecting alcohol preference. Even though the
iP versus P.NP comparison identified 85 significant
trans-regulated probe sets in at least one brain region
and 206 significant probe sets when the data from all 5
regions was averaged (FDR ≤ 0.25; Table 1), no transregulated probe set was common to both experiments.

Discussion
In this study, the iP background strain was compared to
the P.NP congenic strain, which has the iNP chromosome
4 QTL interval between markers D4Rat119 and D4Rat55

introgressed onto the iP background. Because the congenic and background strains are identical except for the
region on chromosome 4, the a priori expectation is that
only cis-regulated genes located in that region of chromosome 4 or genes trans-regulated by genes within that
region should differ. This is expected to be a small set of
genes, the signal from which could be masked by random
variations in the very large set of genes that do not differ.
Among cis-regulated differentially expressed probe sets,
only 53 out of 157 were significant in a single brain region.
Among the other 104 probe sets, 102 differed in the same
direction in at least two regions. Many genes are expected
to be expressed under similar regulatory control in different brain regions, so we also conducted an analysis of the
average expression levels across the five regions and identified additional genes. The magnitude of the differences
was small. Other comparisons of gene expression in rat
brain have also reported small differences [47,58,60-62].
These findings from the iP versus P.NP congenic
strain were then compared with previous transcriptome
profiling of the reciprocal NP.P congenic strain versus
iNP background strain [47]. We identified 74 cis-regulated probe sets with consistent direction and magnitude
of expression differences in the two experiments (Figure
3; Table 3). These are strong candidates for influencing
the alcohol preference phenotype. The differences in
gene expression, although small, were quite consistent
between experiments for these cis-regulated genes
(Table 3, Figure 3). This is noteworthy since the experiments were completely independent, done at two different times using different strains (NP.P versus iNP and
iP versus P.NP) bred at different times, and demonstrates the reproducibility of transcriptome profiling on
microarrays.
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Table 3 Significant probe sets identified by comparison of reciprocal congenic strains
Ratio of expression (iP vs P.NP and NP.P vs iNP)a
Amygdala

Nucleus
accumbens

Frontal
cortex

Hippocampus

Caudate
putamen

Combined
regions

Probe set

Symbol

Gene title

1399134_at

LOC500054

similar to POT1-like telomere end- -1.13 -1.11 -1.13 -1.11 -1.07 -1.18 -1.13
binding protein

-1.22

-1.06 -1.07 -1.10 -1.14

1386777_at

LOC500054

similar to POT1-like telomere end- -1.04 -1.13 -1.10 -1.35 -1.10 -1.21 -1.19
binding protein

-1.29

-1.05 -1.11 -1.10 -1.21

1382865_at

Tsga14

testis specific gene A14

-1.06 -1.09 -1.13 -1.06 -1.05 -1.06 -1.11

-1.10

-1.00 -1.14 -1.07 -1.09

1382409_at
1383828_at

Tsga14
Tsga13

testis specific gene A14
EST-testis specific gene A13
(predicted)
podocalyxin-like

-1.06 -1.12 -1.06 -1.16 -1.09 -1.02 -1.04
-1.25 -1.32 -1.45 -1.25 -1.19 -1.26 -1.57

-1.08
-1.21

-1.09 -1.01 -1.07 -1.08
-1.26 -1.13 -1.34 -1.23

1369895_s_at Podxl

iP NP.P iP NP.P iP NP.P iP
NP.P
iP NP.P iP NP.P
vs.
vs.
vs.
vs.
vs.
vs.
vs. vs. iNP vs.
vs.
vs.
vs.
P.NP iNP P.NP iNP P.NP iNP P.NP
P.NP iNP P.NP iNP

1.04

-1.01

1.00

1.15

1.05

1.01

1.04

1.08

1.03

1.06

1.03

1.06

1378956_at

—

EST-similar to plexin A4

1.55

ND

2.16

ND

1.73

1.55

1.95

1.39

2.28

ND

1.91

1.41

1389291_at

Chchd3

coiled-coil-helix-coiled-coil-helix
domain containing 3

-1.09 -1.10 -1.06 -1.13 -1.06 -1.15 -1.11

-1.10

-1.05 -1.16 -1.08 -1.13

1378824_at

—

1.06

1.08

1.09

ND

1.10

1.08

1.03

1.04

1.09

ND

1.07

1.10

1367734_at

Akr1b1

1.12

1.12

1.22

1.13

1.27

1.29

1.16

1.11

1.25

1.24

1.20

1.18

1395190_at

Akr1b10

EST-4.8 Kb at 3’ side of similar to
solute carrier family 35, member
B4
aldo-keto reductase family 1,
member B1
aldo-keto reductase family 1,
member B10

1.28

1.12

1.55

1.27

1.21

1.21

1.34

1.05

1.23

1.38

1.32

1.20

1382034_at

Akr1b10

aldo-keto reductase family 1,
member B10

1.19

-1.02 -1.41 -1.08

1.09

-1.16 -1.17

-1.05

1.12

1.12 -1.02 -1.04

1383551_at
1388544_at

Bpgm
Bpgm

2,3-bisphosphoglycerate mutase
2,3-bisphosphoglycerate mutase

1.12
1.09

1.10
1.08

1.16
1.14

1.15
1.13

1.10
1.08

1.10
1.06

1.14 -1.07 1.13
1.10 1.11 1.11

1.14
1.10

1.13
1.10

1.09
1.10

1390042_at

Tmem140

transmembrane protein 140

1.21

1.32

1.38

1.24

1.14

1.13

1.11

1.14

1.27

1.06

1.22

1.18

1383598_at

Wdr91

WD repeat domain 91 (Wdr91)

1.33

1.34

1.30

ND

1.47

1.27

1.50

1.23

1.46

1.26

1.41

1.25

1378125_at

—

EST-0.5 Kb at 3’ side of similar to
HSPC049 protein

1.32

1.28

1.46

1.22

1.35

1.32

1.42

1.24

1.42

1.31

1.40

1.27

1373746_at

Wdr91

WD repeat domain 91

-1.21 -1.09 -1.30 -1.14 -1.20 -1.13 -1.26

1373190_at

Cnot4

CCR4-NOT transcription complex,
subunit 4

1.00

1.09

-1.14

-1.18 -1.23 -1.23 -1.14

1.02

1.16

1.07

1.14

1.03

1.02

1.01

1.00

1.03

1.08

1388441_at

LOC689574

hypothetical protein LOC689574

-1.10 -1.03

1.02

-1.06 -1.05 -1.13 -1.08

-1.10

-1.04 -1.09 -1.05 -1.08

1377890_at

—

EST-4.9 Kb at 3’ side of solute
carrier family 13, member 4

1.17

1.50

1.22

1.34

1.16

1.30

1.14

1.23

1.19

1.19

1.18

1.31

1392510_at

Fam180a

family with sequence similarity
180, member A

1.22

1.49

1.78

1.43

1.13

1.08

1.15

1.24

1.08

1.11

1.25

1.26

1391721_at

—

EST-2.5 Kb at 5’ side of
-1.55
cholinergic receptor, muscarinic 2

ND

-2.91

ND

-1.82 -2.10 -1.71

-1.63

-1.88

ND

-1.92 -1.67

1379480_at

Dgki

diacylglycerol kinase, iota

1.13

1.14

1.23

1.22

1.17

1.24

1.26

1.09

1.25

1.27

1.21

1.19

1395107_at

Dgki

EST-similar to diacylglycerol
kinase iota

-1.02

1.04

-1.15

1.06

1.01

-1.01 1.10

1.16

-1.01

1.02

-1.01

1.05

1393410_at

—

EST-0.79 Kb at 5’ side of similar to 1.00
contactin associated protein-like 2
isoform a

-1.18

1.09

1.15 -1.09 -1.11 1.02

-1.06

1.03

1.00

1.01

-1.04

1390393_at

—

EST-5 Kb at 5’ side of similar to
-1.08 -1.15 -1.01
contactin associated protein-like 2
isoform a

1.01 -1.16 -1.21 -1.03

-1.12

-1.03 -1.07 -1.06 -1.11

1370007_at

Pdia4

protein disulfide isomerase
associated 4

1.34

1.10

1.14

1.19

1.06

1.12

1.36

1.14

1397447_at

Zfp398

zinc finger protein 398

-1.04 -1.13 -1.08 -1.08 -1.04

1.01

-1.04

-1.02

-1.06

1.01 -1.05 -1.04

1380094_a_at Zfp212

zinc finger protein 212

1.22

ND

1.28

1.15

1.43

ND

1.24

ND

1.24

1.30

ND

1.21

1.22

1.29

1.16

1.16
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Table 3: Significant probe sets identified by comparison of reciprocal congenic strains (Continued)
1390625_at

RGD1304879 similar to zinc finger protein 398
(zinc finger DNA binding protein
p52/p71)

1.43

1.40

1.27

1.39

1.33

1.20

1.30

1.10

1.07

-1.00 1.09

1.12

1.36

1.46

1.22

1.36

1.31

1.10

1.08

1.08

1377600_at

Znf777

zinc finger protein 777

1.08

1.13

1.08

1.03

1375914_at

Krba1

KRAB-A domain containing 1

-1.04 -1.07 -1.07

1.04

-1.07 -1.02 -1.05

-1.14

-1.06 -1.12 -1.06 -1.06

1371691_at

Rarres2

retinoic acid receptor responder
(tazarotene induced) 2

-1.14 -1.01

1.12

-1.09 -1.16 -1.22 -1.23

-1.19

-1.01 -1.08 -1.08 -1.11

1376401_at

RGD1561107 EST-replication initiator 1

1.12

1.10

1.16

1.13

1.19

1.12

1.13

1.13

1.18

1.14

1.15

1.12

1382755_at

Tra2a

rranscribed locus

1.11

1.16

-1.13 -1.12

1.07

1.20

1.13

1.32

1.11

1.43

1.06

1.19

1387154_at

Npy

neuropeptide Y

-1.04 -1.19 -1.06

1.12 -1.11 -1.11 -1.09

-1.14

-1.08 -1.05 -1.08 -1.07

1380062_at

Mpp6

membrane protein, palmitoylated
6 (MAGUK p55 subfamily
member 6)

1.02

1.00

1.03

-1.09

1.07

1.04

1.13

1.19

1.06

1.02

1.06

1.03

1383324_at

Mpp6

membrane protein, palmitoylated
6 (MAGUK p55 subfamily
member 6)

1.01

1.09

1.10

-1.01 1.11

1.12

1.10

1.20

1.06

1.09

1.07

1.10

1397419_at

Mpp6

membrane protein, palmitoylated
6 (MAGUK p55 subfamily
member 6)

-1.02

1.12

1.12

1.01

1.18

1.13

1.14

1.22

1.07

1.10

1.09

1.11

1397949_at

—

EST-similar to MAGUK p55
subfamily member 6

-1.00

1.13

1.16

1.06

1.15

1.18

1.15

1.20

1.07

1.12

1.10

1.14

1398627_at

—

EST- similar to MAGUK p55
subfamily member 6

-1.01

1.04

1.05

1.10

1.09

1.09

1.07

1.16

1.04

1.02

1.05

1.08

1.07

1384136_at

Osbpl3

oxysterol binding protein-like 3

-1.06 -1.03 -1.09

-1.15 -1.03 -1.12

-1.16

-1.15 -1.06 -1.11 -1.04

1378543_at

Hnrnpa2b1

EST-heterogeneous nuclear
ribonucleoprotein A2/B1
(predicted)

-1.31 -1.23 -1.26 -1.18 -1.17 -1.35 -1.16

-1.16

-1.19 -1.25 -1.22 -1.23

1371395_at

Cbx3

chromobox homolog 3 (HP1
gamma homolog, Drosophila)

-1.07 -1.07 -1.04 -1.00 -1.04 -1.02 -1.03

-1.03

-1.05 -1.10 -1.04 -1.04

1379275_at

Snx10

sorting nexin 10

2.18

1.69

1.58

2.02

EST-sorting nexin 10

-1.10 -1.17 -1.08 -1.05 -1.12 -1.09 -1.06

-1.03

-1.08 -1.26 -1.09 -1.12

1383585_s_at Snx10

1.40

1.67

-1.05 1.94

1.58

1.55

1.89

1.39

1377198_at

—

EST-2 Kb at 3’ side of src family
associated phosphoprotein 2

-1.23 -1.33 -1.16 -1.09 -1.10 -1.09 -1.10

-1.19

-1.03 -1.15 -1.12 -1.17

1369979_at

Skap2

src family associated
phosphoprotein 2

-1.20 -1.22 -1.11 -1.04 -1.03 -1.16 -1.05

-1.07

1.01

1388118_at

Hibadh

3-hydroxyisobutyrate
dehydrogenase

-1.07 -1.01 -1.01 -1.04 -1.05 -1.09 -1.05

-1.03

-1.06 -1.05 -1.05 -1.04

1378742_at

LOC682099

EST-similar to juxtaposed with
another zinc finger protein 1

2.05

1.85

1.76

1.83

1379629_at

—

EST-4.7 kb at 5’ side of similar to
cAMP responsive element
binding protein 5 isoform alpha

-1.38 -1.35 -1.40 -1.37 -1.34 -1.27 -1.42

-1.20

-1.41 -1.34 -1.39 -1.30

1394833_at

—

EST-0.6 Kb at 5’ side of beta
chimerin

-1.12 -1.15 -1.04 -1.19 -1.08

1.02

-1.06

-1.10

1.08

-1.03 -1.04 -1.09

1.01

1.09

1.00

-1.10

1.11

1.12

1370648_a_at Wipf3

1.64

1.18

1.92

-1.01

1.80

1.00

2.11

-1.01

1.71

-1.12 -1.07 -1.12

1.43

1.95

1.02

1.66

1392541_at

Ggct

WAS/WASL interacting protein
family, member 3
gamma-glutamyl cyclotransferase

1.06

-1.34 -1.19 -1.28 -1.06 -1.26 -1.26 -1.18

-1.08

-1.33 -1.26 -1.28 -1.16

1398107_at

Ggct

gamma-glutamyl cyclotransferase

-1.10 -1.15 -1.02

1.14

-1.17

ND

-1.06

-1.07

-1.15 -1.00 -1.10 -1.03

1394973_at

Pde1c

EST-cyclic nucleotide
phosphodiesterase 1 C

1.14

-1.01

1.08

1.09

1.02

1.02

-1.02

-1.01

1.37

1.16

1.11

1.05

1375640_at

Fkbp9

FK506 binding protein 9

-1.05

1.28

1.23

1.01

1.15

1.04

1.02

1.01

1.07

1.05

1.08

1.07

1388493_at

Ecop

EGFR-coamplified and
overexpressed protein

-1.05 -1.10 -1.04 -1.00 -1.10 -1.09 -1.05

-1.05

-1.11 -1.09 -1.07 -1.06

1396215_at

—

EST-similar to RIKEN cDNA
2610022G08

1.01

-1.07 -1.07 -1.10 -1.03 -1.07 -1.08

-1.07

-1.14 -1.20 -1.06 -1.10

1394939_at

Ppm1k

protein phosphatase 1 K (PP2C
domain containing)

-1.74 -2.67 -2.05 -2.36 -2.79 -2.57 -1.86

-2.05

-2.39 -2.05 -2.13 -2.33

1392921_at

Ppm1k

Protein phosphatase 1 K (PP2C
domain containing)

-1.07 -1.22 -1.21 -1.19 -1.12 -1.16 -1.14

-1.22

-1.15 -1.12 -1.14 -1.18
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Table 3: Significant probe sets identified by comparison of reciprocal congenic strains (Continued)
1388778_at

—

EST-3.6 Kb at 5’ side of similar to
protein phosphatase 1 K (PP2C
domain containing)

1367977_at

Snca

synuclein, alpha

1.03

1385271_at

RGD1565731 EST-similar to KIAA1680 protein
(predicted)

-1.02

-1.27 -1.27 -1.27 -1.17 -1.18 -1.27 -1.22

-1.23

-1.22 -1.26 -1.23 -1.24

-1.08 -1.04 -1.11 -1.10 -1.09 1.07

1.03

-1.12 -1.12 -1.03 -1.07

1.04

-1.05 -1.08 -1.03 -1.02 -1.20

-1.11

-1.09 -1.01 -1.08 -1.04

1.33

2.37

1391945_at

—

Transcribed locus

2.01

1.88

1.30

2.61

1393607_at

Grid2

EST-glutamate receptor,
ionotropic, delta 2

-1.27 -1.34 -1.13

1.04 -1.17 -1.14 -1.12

-1.23

-1.02 -1.08 -1.14 -1.14

1386869_at

Actg2

actin, gamma 2, smooth muscle,
enteric

1.03

1.05

-1.11

-1.10

-1.01 -1.02

1.07

1.60

1.54

1.38

1.03

-1.00 -1.06

1.70

2.05

1.01

1.45

-1.03

1379610_at

—

EST

1.19

1.31 -1.00

ND

1.14

1.03

1.24

1.07

-1.03

ND

1.10

1.06

1376481_at

Adamts9

a disintegrin-like and
metalloprotease (reprolysin type)
with thrombospondin type 1
motif, 9

1.09

1.30

1.16

ND

1.22

ND

1.30

1.28

1.27

ND

1.20

1.18

1376747_at

—

EST, strongly similar to membrane -1.11 -1.22
associated guanylate kinase, WW
and PDZ domain containing 1
isoform b [Mus musculus]

1.00

1.05 -1.25 -1.12 1.06

1.02

-1.20 -1.13 -1.09 -1.08

1381871_at
1384504_at

NA
Magi1

Transcribed locus
membrane associated guanylate
kinase, WW and PDZ domain
containing 1

1.21
1.15

1.20
1.05

-1.05
1.05

1.90
1.41

1.28
1.16

1.49
1.20

1.31
1.20

1.42
1.08

1.19
1.08

1.08
1.17

1.18
1.13

1.39
1.17

1397438_at

Magi1

membrane associated guanylate
kinase, WW and PDZ domain
containing 1

1.26

1.01

1.12

1.09

ND

1.02

1.26

ND

1.17

1.08

1.18

1.04

Comparison of iP versus P.NP (this paper) and NP.P versus iNP [47] data. Probe sets that were significant (at P ≤ 0.05) with consistent direction in at least one
brain region or in the average of the brain regions were analyzed. aPositive number is the ratio of the expression level of iP/P.NP (this paper) or NP.P/iNP [47]
(that is, in both cases expression is higher in the strain with the P alleles in the introgressed region); negative numbers indicate the ratio of expression level of P.
NP/iP (this paper) or iNP/NP.P [47]. Bold numbers indicate significant ratio of expression. ND indicates not detectable. The probe sets were sorted by genomic
location; all are on chromosome 4.

In these comparisons between congenic animals, the
only genes outside the chromosome 4 QTL region that
are expected to show differential expression are those
that are trans-regulated by genes lying within the region.
Fewer trans-regulated genes showed differential expression in any one brain region, whereas analyzing the
average expression values resulted in more trans-regulated genes (Table 1). However, most of these were not
common to the reciprocal congenic experiment [47],
suggesting that most of these trans-differences could be
false positives.
Of the 74 cis-regulated candidate genes common to the
reciprocal congenic experiments and the most significant
trans-regulated candidate genes from the iP vs P.NP
comparison, 10 genes were chosen for PCR confirmation
based on their expression differences and/or literature
reports of their possible involvement in pathways related
to alcohol-seeking behavior. Of these, 79% showed consistent direction of expression, in part because RT-PCR
is a logarithmic process and not as good for detecting
small differences in expression (Table 2). The primers
for these confirmation studies, when possible, were in
the coding sequences spanning an intron. It has been
our experience that when primers are designed based on

the coding regions, as we did here, the number of confirmed genes is lower (50 to 70%) than when using primers designed within the 3’ sequences used on the
microarray chips (80 to 90%), perhaps due in part to
alternative splicing or 3’ untranslated regions. A limitation of this confirmation was that samples were pooled
by brain region, limiting the statistical power for data
analysis.
Sorting nexin10 (Snx10) is one of the most significant
genes identified in both reciprocal congenics. Snx10
protein is a member of sorting nexins, a diverse group
of cellular trafficking proteins that are unified by the
presence of a phospholipid-binding motif, the PX
domain. Snx10 protein may be involved in the regulation of endosome homeostasis [63]. In four of the brain
regions we studied, the animals with the iP chromosome
4 QTL segment (iP and NP.P) demonstrated a higher
expression of Snx10 mRNA than those with the iNP
segment (iNP and P.NP; Table 3).
Ppm1k is a serine/threonine protein phosphatase.
Together with other protein kinases, these enzymes control the state of phosphorylation of cell proteins and
thereby provide an important mechanism for regulating
cellular activity.
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Figure 3 Differential expression is highly correlated between the reciprocal congenic lines. There were 74 probe sets within the
chromosome 4 QTL that were at P ≤ 0.05 in the same brain region (or in the average) in both experiments, and with a consistent expression
direction (Table 3). Data from the average of brain regions was plotted as Log2 of the expression in NP.P/iNP (x-axis) versus log2 ratio of iP/P.NP
(y-axis). Three probe sets have the same expression direction in the same brain region but not in the average of brain regions (red triangles) and
include: EST-similar to Diacylglycerol kinase iota (DGKi); EST-0.79 Kb at 5’ side of similar to contactin associated protein-like 2 isoform a
(LOC500105); and actin, gamma 2, smooth muscle, enteric (Acgt2).

Aldo-keto reductase 1 member B1 (Akr1b1), and
Akr1b10 catalyze the reduction of aliphatic and aromatic aldehydes to their corresponding alcohols. These
two genes are both expressed at higher levels in the animal with the P chromosome 4 interval than the animal
with the iNP chromosome 4 interval in both iP versus
P.NP and NP.P versus iNP comparisons. Although
sepiaperterin reductase (SPR) is known to be the major
enzyme in the tetrahydrobiopterin (BH4) synthesis,
aldo-keto reductases (AKRs) and carbonyl reductases
(CBRs) can also convert 6-pyruvoyltetrahydropterin to
BH4 [64-66], which is an essential cofactor for tyrosine
hydroxylase (TH) and tryptophan hydroxylase (TPH),
both of which are involved in dopamine and serotonin
biosynthesis (Figure 4). Alcohol is known to interact

with the dopamine and serotonin neurotransmitter systems in the brain.
Diacylglycerol kinase (Dgki) regulates the levels of various pools of diacylglycerol (DAG), affecting DAGmediated signal transduction. We found that Dgki
mRNA is expressed at higher levels in animals with the
iP chromosome 4 QTL interval (iP and NP.P) than
those with the iNP interval (P.NP and iNP) in all the
brain regions studied. Dgki mRNA has been shown to
be expressed at higher levels in discrete brain regions of
the alcohol accepting (AA) rats than in the alcohol nonaccepting (ANA) rats [67]. The highest mRNA expression of Dgki was found in the human brain [68]. Dgki is
expressed in the cytoplasm of most dorsal root ganglion
neurons, through which primary afferent information
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Figure 4 Candidate genes in the dopamine and serotonin system. Sepiaperterin reductase (SPR) and aldo-keto reductase (AKR) reduces an
intermediate, 6-pyruvoyl-tetrahydropterin (PPH4), to 1’-OXPH4, or 2’-OXPH4, and catalyzes the final step of tetrahydrobiopterin (BH4) synthesis, an
essential cofactor for phenylalanine hydroxylase, tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH) and nitric oxide synthase (NOS) [65,66].
Quinoid dihydropteridine reductase (QDPR) mediates reduction of quinonoid dihydrobiopterin. Several candidate genes are related to dopamine
function. Snca regulates dopamine biosynthesis and attenuates dopamine transporter activity. Scap2 phosphorylates Snca, and Copg2 is involved
in the transport of the dopamine receptor 1 (D1). Arrows represent metabolic steps, and dashed lines represent genes that are functionally
related. Identified candidate genes are in boxes; gray color indicates a lower expression in iP and white color indicates higher expression in iP.
GTPCH, GTP-cyclohydrolase I; PTPS, 6-pyruvoyltetrahydropterin synthase; 1’-OXPH4, 1’-oxo-2’-hydroxypropyl tetrahydropterin; 2’-OXPH4, 1’-hydroxy2’-oxo-tetrahydropterin; OH-4a-BH4, pterin-4a-carbinolamine; PCD, pterin-4a-carbinolamine dehydratase.
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passes en route to the brain [69]. Dgki catalyzes the
phosphorylation of DAG, an activator of protein kinase
C, to phosphatidic acid, and thus down-regulates second
messenger pathways activated by protein kinase C,
which play important roles in regulating behavioral
responses to ethanol [70].
Protein disulfide isomerase family A, member 4
(Pdia4), also known as endoplasmic reticulum p72
(ERp72) [71], functions in disulfide bond formation and
isomerization. Together with other endoplasmic reticulum-resident molecular chaperones, Pdia4 protein participates in critical steps in the folding of apolipoprotein
B before any substantial lipidation occurs. Pdia4 mRNA
was differentially expressed in four microarray gene profiling studies using animals selected for high and low
alcohol consumption, which include iP versus iNP [58],
inbred high-alcohol-drinking (iHAD) versus inbred lowalcohol-drinking (iLAD) (unpublished data), NP.P versus
iNP [47], and iP versus P.NP (this paper). In all these
studies, the animals with the high drinking allele had
higher levels of Pdia4 mRNA than the animals that had
the low drinking allele.
NPY is one of the most abundant neuropeptides in
the central nervous system, and has been shown to have
multiple functions, including regulation of feeding behavior, anxiety, addiction, bone density and memory retention [72,73]. In the present study, Npy expression has
the same trend in all five brain regions, with lower
expression in animals with the iP chromosome 4 QTL
interval; this is consistent with previous findings of
lower expression in iP than in iNP animals [43]. Alcohol
consumption is inversely related to NPY levels in the
brain [43,74]. Intracerebroventricular administration of
NPY significantly decreased ethanol intake in P rats
[75].
Snca is a previously identified candidate gene for
alcohol consumption in the iP/iNP animals [42,47],
and has been associated with craving and alcohol
dependence in humans [31,76]. In both microarray
comparisons,Snca was found expressed at lower levels
in the frontal cortex and caudate of animals with the
iP QTL interval. However, an opposite trend was
observed in the hippocampus, where Snca was previously shown to have higher expression in iP rats
[42]. Higher mRNA and protein levels have been
observed in serum from alcoholic patients compared
to that from controls [77,78]. SNCA has been associated with craving and alcohol dependence in humans
[31,76]. Skap2 and Fyn-kinase were previously identified as being involved in the phosphorylation of Snca
(Figure 4). Scap2 is expressed at lower levels in NP.P
than iNP and also lower in iP than P.NP; it inhibits
the phosphorylation of Snca and acts as a substrate for
the Src family of kinases, such as Fyn [79]. Fyn
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specifically phosphorylates tyrosine residue 125 of Snca
[80]. Snca and Fyn are co-localized in subcellular
structures and expressed in similar brain regions [80].
Miyakawa and colleagues found that Fyn-kinase is
involved in ethanol sensitivity through NMDA-receptor function [81]. Thus, these genes could work in
concert to control alcohol seeking behavior.
A limitation of microarray technology is that a SNP
that differs between the two strains tested could affect
the hybridization to a probe set in a way that mimics an
expression difference. Because expression data are composites from many probe sets, this is likely to make only
a small difference. To address this possibility, individual
probes within each of the 74 strong candidate probe
sets were analyzed. There were no detectable SNP
effects in 71 of these genes; only 3 genes had one probe
that differed from the overall pattern (data not shown).
This indicated that the majority of expression differences detected in this study were not the result of SNP
effects.
Ingenuity Pathways Analysis (Ingenuity Systems, Inc.,
Mountain View, CA, USA) of the genes significant in
either experiment (iP versus P. NP or NP.P versus iNP,
at FDR <0.25) was performed. The dopamine and serotonin biosynthesis and other pathways - for example,
the Nfkb1 pathway - were overrepresented. Six candidate genes, including Akr1b1, Qdpr, Snca, Spr, Scap2,
and Copg2, are directly or indirectly involved with the
dopamine and serotonin biosynthesis pathway (Figure
4). Confirmation of candidate genes in the Nfkb1 pathway, which is associated with alcohol dependence [26],
is ongoing.

Conclusions
Two independent gene profiling experiments using reciprocal congenic strains have identified strong, cis-acting
candidate genes for alcohol consumption within the
chromosome 4 QTL region. These findings provide
important candidate genes for future functional and
knockout studies.
Materials and methods
Animals

Creation of the P.NP-(D4Rat119 (62.8 Mb)-D4Rat55
(127.9 Mb) congenic strain has been previously
described [44]. Briefly, it was initiated by crossing one
male rat from the iNP strain with one female rat from
the iP strain to create iP × iNP F1 animals, which were
backcrossed to the iP strain to produce the N2 generation. Ten generations of backcrossing to the iP strain
were performed, followed by an intercross between N10
animals to produce homozygous animals (N10F1),
which resulted in the finished congenic P.NP strain
(Figure 1).
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Presence of the chromosome 4 interval was confirmed
using four to five microsatellite markers, including
D4Rat119 and D4Rat55. Microsatelitte markers at 47.8
Mb (D4Rat15) and 159.3 Mb (D4Rat192) defined the
extent of the introgressed region for both the P.NP and
the NP.P congenic strains. At microsatelitte markers
62.8 Mb (D4Rat119) and 127.9 Mb (D4Rat55), the NP.P
strain was homozygous for the iP allele and the P.NP
strain was homozygous for the iNP allele. Although the
locations of the recombination boundaries have not
been resolved, they are between 62.8 Mb and 47.8 Mb
and between 127.9 Mb and 159.3 Mb [44]. The QTL
map in Figure 2 was generated using our published data
[51] plus additional markers using MAPMAKER/EXP82;
the 95% confidence interval was calculated [83] and it
spans 54.8 Mb to 105 Mb.
All animal housing and handing was as previously
described [47]. The animals used in these experiments
were maintained in facilities fully accredited by the
Association for the Assessment and Accreditation of
Laboratory Animal Care (AAALAC). All research protocols were approved by the Institutional Animal Care
and Use Committee and are in accordance with the
guidelines of the Institutional Animal Care and Use
Committee of the National Institute on Drug Abuse,
NIH, and the Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources,
Commission on Life Sciences, National Research Council 1996).
A total of 16 (8 iP and 8 P.NP) male rats, 14 to 15
weeks of age, were sacrificed by decapitation between
0900 and 1000 hours over two consecutive days, with
equal numbers of animals from each strain sacrificed
each day. The head was immediately immersed in
chilled isopentane (-50°C) for 15 seconds and then
placed in a cold box maintained at -15°C, where the
brain was rapidly removed and placed on a glass plate
for dissection. All equipment used to obtain tissue was
treated with RNaseZap (Ambion, Inc. Austin, TX, USA)
to prevent RNA degradation. The amygdala, nucleus
accumbens, caudate putamen, frontal cortex, and hippocampus were dissected as previously described [84].
RNA isolation

Dissected tissues were immediately homogenized in Trizol reagent (Invitrogen, Carlsbad, CA, USA) and processed according to the manufacturer’s protocol, but
with triple the suggested ratio of Trizol to tissue [60].
RNA was further purified through RNeasy® mini columns (Qiagen, Valencia, CA, USA), according to the
manufacturer’s protocol. To avoid genomic DNA contamination in the real-time PCR assay, the RNA was
treated with DNase I. Total RNA yields from the iP and
P.NP groups were similar (P > 0.4). The quality of the
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RNA from all rats and regions was similar, as monitored
by absorbance spectra from 210 to 350 nm, by electrophoresis on 1% agarose gels, and using the Agilent Bioanalyzer to confirm the ribosomal bands.
RNA labeling and microarray hybridization

RNA from each brain region of each individual rat was
labeled and hybridized separately on an Affymetrix Rat
Genome 230 2.0 microarray. Starting with 5 μg of total
RNA from each animal, biotinylated cRNA was produced using the GeneChip® Expression 3’ Amplification
One-Cycle Target Labeling and Control Reagents kit
according to Affymetrix standard protocol. Fragmented,
biotinylated cRNA (15 μg) was mixed into 300 μl of
hybridization cocktail, of which 200 μl was used for
each hybridization. Hybridization was for 17 hours at
42°C. Washing, staining, and scanning were carried out
according to the standard protocol.
To minimize systematic errors, all stages of the experiment were balanced across phenotypes. That is, equal
numbers of P.NP and iP animals were sacrificed each
day, and equal numbers of RNA preparations from iP
and P.NP animals were processed through the labeling,
hybridization, washing and scanning protocols on each
day, in different alternating orders. Whenever possible,
common premixes of reagents were used.
Data analysis and informatics

Each GeneChip® was scanned using an Affymetrix
Model 3000 scanner and underwent image analysis
using Affymetrix GCOS software. Microarray data are
available from the National Center for Biotechnology
Information’s Gene Expression Omnibus [85,86], under
series accession [GEO:GSE15415] [87]. Raw cel files
were imported into the statistical programming environment R for further analysis with tools available from the
Bioconductor Project [88]. Expression data were normalized and log 2 transformed using the RMA method
[89,90] implemented in the Bioconductor package RMA.
Our primary hypothesis was that cis-regulated genes
within the QTL were responsible for the strain differences; thus, to detect genes within the region that differed between the P.NP and iP rats, the probe sets that
mapped to the chromosome 4 QTL region between
microsatellite markers D4Rat151 and D4Rat55 that
flanked the introgressed region (from 29,413,686 to
128,186,835 bases) were analyzed using t-tests, calculated using the package Limma [91]. To increase power
and decrease the false discovery rate [92], probe sets not
reliably detected on at least one-third of the microarrays
in at least one experimental group (using the Affymetrix
Microarray Analysis Suite 5.0 detection call) were not
analyzed [93]. For the analyses of a specific brain region,
the QTL probe sets were retained if present on at least
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one-third of the microarrays for either the congenic P.
NP or iP animals (number of probe sets detected ranged
from 644 to 694). To detect differences in gene expression common to several regions, data from the five discrete brain regions of each animal were averaged. This
reduces random technical variation from the individual
extractions and labeling, and thereby provides more
power to detect differences that are in the same direction in multiple regions but may fall below significance
in individual regions. For the analyses of average expression level, QTL probe sets were retained if present on at
least one-third of the microarrays in at least one brain
region in at least one strain (690 probe sets).
Secondary analyses examined expression differences
elsewhere in the genome that could arise from transacting factors within the region. For the analyses of a
specific brain region, the probe sets were retained if present on at least one-third of the microarrays for either
the congenic P.NP or iP animals (21,345 to 22,994
probe sets). For the analyses of average expression level,
probe sets were retained if present on at least one-third
of the microarrays in at least one brain region in at least
one strain (23,050 probe sets).
Comparison of reciprocal congenics

Previously published data comparing expression in NP.P
versus iNP congenics [47] were compared to the present
data (iP versus P.NP) to identify probe sets that exhibited consistent expression differences between the two
experiments. For both experiments we calculated the
ratio of expression from the animals carrying the iP
QTL region to that from the animals carrying the iNP
QTL region (that is, NP.P/iNP and iP/P.NP). Thus, for
both experiments, a positive ratio of expression represents higher expression in the animals with the iP chromosome 4 QTL interval (iP and NP.P), and a negative
value represents lower expression in the animals with iP
chromosome.
Because the earlier experiment was less powerful
(comparing only six animals from each strain) and
because we could use the consistency of results from
the two experiments to filter out false positives, we
relaxed the level of significance to P ≤ 0.05 for this comparison to reduce false negatives. Any false positives
introduced by this relaxation should not be consistent
between the two independent experiments. Thus, genes
that were significant in the two experiments (at P ≤
0.05) in the same brain region or in the average of the
brain regions and with consistent direction in both
experiments were identified (Table 3).
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analysis according to the method of Rostoks, Borevitz,
et al. [94]. Briefly, probe level expression was extracted
from individual CEL files from all five brain regions
after background correction. Expression levels for individual probes were averaged within animal, across brain
regions, in a manner identical to that applied to probe
sets. An algorithm was applied to the probes belonging
to each probe set such that overall probe set group differential expression was ascertained and then each
probe’s expression was corrected for this. This made it
easier to identify individual probes with relatively small
deviations from large overall group differential expressions. For each probe set, the differential expression of
each probe was then plotted using the matplot function
of Bioconductor package affyPLM [95,96].
Mapping of ESTs

In order to map the genomic location of significant
ESTs, sequences were obtained from the Affymetrix
website [97] and aligned to the rat genome using
BLAST at NCBI [98]. Probe sets that aligned within a
gene were referred to by that gene name. Probe sets
that aligned between genes were listed as the nearest
gene with the distance noted. ESTs that aligned to multiple loci or could not be positioned on the genome
were labeled as EST.
Quantitative real-time PCR

Ten genes were selected for confirmation in the five
brain regions used in the microarray analysis, using
qRT-PCR. Amplification primers were designed from
the sequence in the coding region of the gene using
Vector NTI (Invitrogen); when possible, at least one primer spanned an exon/intron boundary. qRT-PCR was
carried out using SYBR Green chemistry and the ABI
Prism 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) as previously described
[47]. To correct for sample-to-sample variation, an
endogenous control (glyceraldehyde 3-phosphate dehydrogenase, GAPDH) was amplified with the target and
served as an internal reference to normalize the data.
The average GAPDH Ct values for iP and P.NP were
the same in each brain region tested, making this an
appropriate control gene to normalize the expression of
the candidate genes of interest. Relative quantification
was performed using the standard curve method
(Applied Biosystems, User Bulletin #2) [99]. For each
pooled iP and P.NP sample, eight animals were pooled
by each of five brain regions and six technical replicates
were performed.

SNP effect analysis

Ingenuity pathway analysis

Potential chromosomal regions containing SNPs were
identified using probe, as opposed to probe set, level

The interactions between differentially expressed genes
in either comparisons (with FDR <0.25) were
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investigated using Ingenuity Pathway Analysis (IPA 5.0;
Ingenuity Systems, Inc., Mountain View, CA). The differentially expressed genes were uploaded into IPA.
Each gene identifier was mapped to its corresponding
gene in the Ingenuity Pathway Knowledge Base, a manually curated database of interactions from literature
[100]. These genes were overlaid onto a global network
developed from the information contained in the Ingenuity Pathway Knowledge Base. Networks of these
genes, defined as the reflection of all interactions of a
given gene defined in the literature, were then algorithmically generated based on their connectivity. The interactions indicate physical association, induction/
activation or repression/inactivation of one gene product
by the other, directly or through another intermediary
molecule.
Additional file 1: iP-PNP supplemental tables Supplemental data of
expression profiling in alcoholpreferring and non-preferring reciprocal
congenic rats.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/gb-2010-11-2r11-S1.xls ]
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